Literature DB >> 16966601

Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion.

Osnat Rosen1, Michal Sharon, Sabine R Quadt-Akabayov, Jacob Anglister.   

Abstract

HIV-1 coreceptor usage plays a critical role in virus tropism and pathogenesis. A switch from CCR5- to CXCR4-using viruses occurs during the course of HIV-1 infection and correlates with subsequent disease progression. A single mutation at position 322 within the V3 loop of the HIV-1 envelope glycoprotein gp120, from a negatively to a positively charged residue, was found to be sufficient to switch an R5 virus to an X4 virus. In this study, the NMR structure of the V3 region of an R5 strain, HIV-1(JR-FL), in complex with an HIV-1-neutralizing antibody was determined. Positively charged and negatively charged residues at positions 304 and 322, respectively, oppose each other in the beta-hairpin structure, enabling a favorable electrostatic interaction that stabilizes the postulated R5 conformation. Comparison of the R5 conformation with the postulated X4 conformation of the V3 region (positively charged residue at position 322) reveals that electrostatic repulsion between residues 304 and 322 in X4 strains triggers the observed one register shift in the N-terminal strand of the V3 region. We posit that electrostatic interactions at the base of the V3 beta-hairpin can modulate the conformation and thereby influence the phenotype switch. In addition, we suggest that interstrand cation-pi interactions between positively charged and aromatic residues induce the switch to the X4 conformation as a result of the S306R mutation. The existence of three pairs of identical (or very similar) amino acids in the V3 C-terminal strand facilitates the switch between the R5 and X4 conformations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966601      PMCID: PMC1599894          DOI: 10.1073/pnas.0606312103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Evidence of turn and salt bridge contributions to beta-hairpin stability: MD simulations of C-terminal fragment from the B1 domain of protein G.

Authors:  Jerry Tsai; Michael Levitt
Journal:  Biophys Chem       Date:  2002-12-10       Impact factor: 2.352

2.  The geometry and efficacy of cation-pi interactions in a diagonal position of a designed beta-hairpin.

Authors:  Chad D Tatko; Marcey L Waters
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

3.  Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity.

Authors:  Michal Sharon; Naama Kessler; Rina Levy; Susan Zolla-Pazner; Matthias Görlach; Jacob Anglister
Journal:  Structure       Date:  2003-02       Impact factor: 5.006

4.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.

Authors:  J J De Jong; A De Ronde; W Keulen; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  The hydrophobic moment detects periodicity in protein hydrophobicity.

Authors:  D Eisenberg; R M Weiss; T C Terwilliger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.

Authors:  R A Fouchier; M Groenink; N A Kootstra; M Tersmette; H G Huisman; F Miedema; H Schuitemaker
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  HIV-1 tropism and co-receptor use.

Authors:  M T Dittmar; A McKnight; G Simmons; P R Clapham; R A Weiss; P Simmonds
Journal:  Nature       Date:  1997-02-06       Impact factor: 49.962

9.  Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

Authors:  S Matsushita; H Maeda; K Kimachi; Y Eda; Y Maeda; T Murakami; S Tokiyoshi; K Takatsuki
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

10.  Stabilization of beta-hairpin peptides by salt bridges: role of preorganization in the energetic contribution of weak interactions.

Authors:  Barbara Ciani; Muriel Jourdan; Mark S Searle
Journal:  J Am Chem Soc       Date:  2003-07-30       Impact factor: 15.419

View more
  35 in total

1.  Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of HIV-1 gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first and second heptad repeats (HR1 and HR2) of gp41.

Authors:  Wei Wang; Christopher J De Feo; Min Zhuang; Russell Vassell; Carol D Weiss
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

2.  Conserved structural elements in the V3 crown of HIV-1 gp120.

Authors:  Xunqing Jiang; Valicia Burke; Maxim Totrov; Constance Williams; Timothy Cardozo; Miroslaw K Gorny; Susan Zolla-Pazner; Xiang-Peng Kong
Journal:  Nat Struct Mol Biol       Date:  2010-07-11       Impact factor: 15.369

3.  Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.

Authors:  Ralph Pantophlet; Rowena O Aguilar-Sino; Terri Wrin; Lisa A Cavacini; Dennis R Burton
Journal:  Virology       Date:  2007-04-06       Impact factor: 3.616

4.  Crystal structure of a soluble cleaved HIV-1 envelope trimer.

Authors:  Jean-Philippe Julien; Albert Cupo; Devin Sok; Robyn L Stanfield; Dmitry Lyumkis; Marc C Deller; Per-Johan Klasse; Dennis R Burton; Rogier W Sanders; John P Moore; Andrew B Ward; Ian A Wilson
Journal:  Science       Date:  2013-10-31       Impact factor: 47.728

5.  Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.

Authors:  Andreja Majerle; Primoz Pristovsek; Mateja Mancek-Keber; Roman Jerala
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

6.  An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120.

Authors:  Adi Moseri; Subramanyam Tantry; Yael Sagi; Boris Arshava; Fred Naider; Jacob Anglister
Journal:  Virology       Date:  2010-03-26       Impact factor: 3.616

7.  Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?

Authors:  Richard M Gibson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

8.  Prediction of co-receptor usage of HIV-1 from genotype.

Authors:  J Nikolaj Dybowski; Dominik Heider; Daniel Hoffmann
Journal:  PLoS Comput Biol       Date:  2010-04-15       Impact factor: 4.475

9.  Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.

Authors:  Amit Mor; Eugenia Segal; Brenda Mester; Boris Arshava; Osnat Rosen; Fa-Xiang Ding; Joseph Russo; Amnon Dafni; Fabian Schvartzman; Tali Scherf; Fred Naider; Jacob Anglister
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

10.  Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

Authors:  Jan Weber; Ana C Vazquez; Dane Winner; Richard M Gibson; Ariel M Rhea; Justine D Rose; Doug Wylie; Kenneth Henry; Alison Wright; Kevin King; John Archer; Eva Poveda; Vicente Soriano; David L Robertson; Paul D Olivo; Eric J Arts; Miguel E Quiñones-Mateu
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.